Manufacturing of cGMP Grade Recombinant Human Laminin 521 Based on the CAP-Go Expression System.

Jens Wölfel1, Simon Fradin1, Silke Wissing1, Corinna Bialek1, Tanja Kahlau1, Christian Niehus1, Helmut Kewes1, Thomas Mundt1, Zhijie Xiao2, Yi Sun2; Nicole Faust1

Presented at: ESACT 2017 (Cell Technologies for Innovative Therapies), May 14 – 17, 2017, Lausanne, Switzerland